An expression of concern on Discoidin Domain Receptors: Potential Actors and Targets in Cancer

Bibliographic Details
Main Author:	Frontiers Editorial Office (Author)
Format:	Book
Published:	Frontiers Media S.A., 2016-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Discoidin Domain Receptors: Potential Actors and Targets in Cancer
by: Hassan eRammal, et al.
Published: (2016)

Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease
by: Corina M. Borza, et al.
Published: (2022)

Discoidin domain receptors; an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism
by: Renny T. Franceschi, et al.
Published: (2023)

The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2
by: Ria Aryani Hayuningtyas, et al.
Published: (2021)

Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells
by: Zhenyu Xu, et al.
Published: (2019)

Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
by: Ashraf K. El-Damasy, et al.
Published: (2024)

Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis
by: Xiaoli Li, et al.
Published: (2022)

Expression of Concern: Human and Environmental Dangers Posed by Ongoing Global Tropospheric Aerosolized Particulates for Weather Modification
by: Frontiers Editorial Office
Published: (2016)

Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
by: Frontiers Editorial Office
Published: (2023)

Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease
by: Marsel Lino, et al.
Published: (2020)

Expression of Concern: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze
by: Frontiers Editorial Office
Published: (2017)

Expression of Concern: The Effects of Vitamin D Supplementation on Signaling Pathway of Inflammation and Oxidative Stress in Diabetic Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Frontiers Editorial Office
Published: (2020)

Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosis
by: Qi Wang, et al.
Published: (2022)

Statement of Concern: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
by: Frontiers in ePharmacology Editorial Office
Published: (2016)

Retraction: Astragali radix isoflavones synergistically alleviate cerebral ischemia and reperfusion injury via activating estrogen receptor-PI3K-Akt signaling pathway
by: Frontiers Editorial Office
Published: (2023)

Retraction: Yizhi Qingxin formula extract ameliorates cognitive decline in aged rats via the brain-derived neurotrophic factor/tropomyosin receptor kinase B pathway
by: Frontiers Editorial Office
Published: (2024)

Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn
by: Frontiers Editorial Office
Published: (2017)

Retraction: Effects of dexmedetomidine on postoperative delirium and expression of IL-1β, IL-6, and TNF-α in elderly patients after hip fracture operation
by: Frontiers Editorial Office
Published: (2024)

Erratum: Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
by: Frontiers Production Office
Published: (2023)

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles
by: Eric Voltà-Durán, et al.
Published: (2022)

Retraction: microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis via the MAPK Signaling Pathway Through Targeting SOCS1
by: Frontiers Editorial Office
Published: (2022)

Erratum: Targeted ferroptotic potency of ferrous oxide nanoparticles-diethyldithiocarba mate nanocomplex on the metastatic liver cancer
by: Frontiers Production Office
Published: (2023)

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990
by: Frontiers Editorial Office
Published: (2023)

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
by: Frontiers Editorial Office
Published: (2022)

Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
by: Frontiers Editorial Office
Published: (2023)

Retraction: pH responsive polymer micelles enhances inhibitory efficacy on metastasis of murine breast cancer cells
by: Frontiers Editorial Office
Published: (2023)

Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway
by: Frontiers Editorial Office
Published: (2023)

Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor
by: Frontiers Editorial Office
Published: (2023)

N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review
by: Ye Chen, et al.
Published: (2024)

Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
by: Hamid Bakherad, et al.
Published: (2020)

Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors
by: Frontiers Production Office
Published: (2024)

Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies
by: Herve Emonard
Published: (2016)

Erratum: Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
by: Frontiers Production Office
Published: (2022)

Domains of Students’ Concerns in Oral Diagnosis and Surgery Clinic
by: Fliah Hassan A, et al.
Published: (2023)

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
by: Denise Guerra, et al.
Published: (2024)

Mesenchymal Stem Cells after Polytrauma: Actor and Target
by: Markus Huber-Lang, et al.
Published: (2016)

Expression of Concern: Rahman et al. An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance. <i>Antibiotics</i> 2022, <i>11,</i> 667
by: Antibiotics Editorial Office
Published: (2024)

Expression of Concern: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma
by: Pathology & Oncology Research Editorial Office
Published: (2023)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Frontiers Production Office
Published: (2019)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
by: Peter J. Halfmann, et al.
Published: (2021)

An expression of concern on Discoidin Domain Receptors: Potential Actors and Targets in Cancer

Similar Items

Similar Items